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S UlTIITIary 
The Ca2+/calmodulin-dependent  protein kinase (CaMK) type IV/Gr is selectively expressed 
in T lymphocytes and is activated after signaling via the T  cell antigen receptor (TCR), indicat- 
ing that it mediates some of the Ca2+-dependent transcriptional events that follow TCR  en- 
gagement. Here we show that CaMKIV/Gr induces the transcription factor activation protein 
1 (AP-1) alone or in synergy with T  cell mitogens and with the p21 ra~ oncoprotein. CaMKIV/ 
Gr signaling is associated with transcriptional activation of c-fos but is independent of p21 ~  or 
calcineurin. AP-1  is an integral component of the nuclear factor of activated T  cells  (NFAT) 
transcriptional  complex, which  is required  for interleukin  2  gene  expression in T  cells.  We 
demonstrate that CaMKIV/Gr reconstitutes the capacity of the cytosolic component of NFAT 
to direct transcription from NFAT sites in non-T cells.  These results reveal a central role for 
CaMKIV/Gr as a Ca2+-regulated activator of gene transcription in T  lymphocytes. 
C  a2+  signaling  pathways play  a  particularly  important 
role in lymphocyte biology. Elevation of free intracel- 
lular Ca  2§  concentrations after engagement of lymphocyte 
antigen receptors is required for a broad array of events in 
the  course  of lymphocyte  development  and  activation. 
These include positive and negative selection of developing 
lymphocytes,  induction  of lymphocyte  prohferation  and 
lymphokine  gene  expression,  and  activation-induced  cell 
death.  Previous studies have identified the CaZ+/calmodu  - 
lin-dependent phosphatase calcineurin as an important me- 
diator of Ca  2+ signaling in lymphocytes (1,  2).  Calcineurin 
is critical for the induction of lymphokine gene expression 
in response to T  cell mitogens, and its inhibition by the im- 
munosuppressive  agents  cyclosporin  and  FK506  leads  to 
the suppression oflymphokine gene transcription (3). 
In  addition  to  calcineurin,  lymphocytes  express  other 
Ca2+/calmodttlin-binding proteins, prominent among which 
are  the  multifunctional  Ca2+/calmodulin-dependent  pro- 
tein kinases (CaMKs) t. These serine/threonine-specific pro- 
tein  kinases,  which  include  CaMKI,  II, and  IV/Gr, have 
1Abbreviations used in this paper: AP-1, activation  protein 1; CaMK, Ca2+/ 
calmodulin-dependent protein kinase; mutants: CaMKII(c),  constitutively 
active CaMKID/B; CaMKIV/Gr(i), inactive CaMKIV/Gr; CaMK1V/ 
Gr(wt), wild-type CaMKIV/Gr; ACaMKIV/Gr(c),  constitutively active 
CaMKIV/Gr; ACaMKIV/Gr(i), double mutant constitutive/inactive; 
CAT, chloramphenicol acetyl transferase; NFATc, cytosolic component 
of NFAT; NFAT, nuclear factor of activated T cells. 
broad substrate specificity and serve to regulate a wide array 
of cellular processes (4). Of these enzymes, CaMKIV/Gr is 
of special interest in that its  expression is largely restricted 
to T  lymphocytes and neurons  (5,  6).  CaMKIV/Gr is the 
product of a single gene and is expressed in tissues  as two 
monomeric isoforms, both of which share a domain struc- 
ture common to other CaMKs and that includes a catalytic 
domain,  a calmodulin-binding domain,  and an associative 
domain  (7-10).  Previous  studies  have  documented  the 
presence of CaMKIV/Gr in the nucleus  (11,  12),  and the 
kinase  has been shown to phosphorylate and transactivate 
the  transcription  factor  cAMP  response  element  binding 
protein  (12-15),  establishing a  role  for CaMKIV/Gr as  a 
Ca2+-dependent transcriptional regulator. 
In T  lymphocytes, CaMKIV/Gr is selectively enriched 
in the CD4 § subpopulation. When isolated from resting T 
cells it exhibits minimal catalytic activity even in the pres- 
ence of Ca  2+ and calmodulin. Its activity is strongly upreg- 
ulated  upon antigen  receptor stimulation  (6,  16,  17)  by a 
mechanism involving a protein kinase cascade (17,  18). This 
indicated that CaMKIV/Gr may play a role in Ca2+-depen  - 
dent  transcriptional  events  triggered  by  antigen  receptor 
signaling that are critical to the helper functions of T  cells, 
namely the production of lymphokines.  In this  study,  we 
examined  the  capacity  of CaMKIV/Gr  to  activate  lym- 
phokine  gene  transcription  using  the  IL-2 promoter as  a 
model. Our results demonstrate that CaMKIV/Gr plays an 
important role in promoting IL-2 gene transcription, in part 
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duction of the transcription factor activation protein 1 (AP-1). 
Materials and Methods 
Cells.  Jurkat  Tag  cells are  derived from  the Jurkat  human 
leukemia T  cell line and stably express the SV40 large T antigen 
(2). They were maintained in RPMI 1640 medium supplemented 
with 10% FCS. BJAB, an EBV-negative Burkitt lymphoma B cell 
line, and HeLa,  a cervical adenocarcinoma cell line, were main- 
tained in DMEM medium supplemented with 10% FCS. 
Plasmids.  FLAG epitope-tagged wild-type human CaMKIV/ 
Gr  (CaMKIV/Gr[wt])  was  derived  and  subcloned into  pSG5 
vector  as  described  (11). CaMKIV/Gr(wt)  contains an  eight- 
amino acid FLAG epitope at its NH  2 terminus to allow detection 
by immunoblotting. Inactive CaMKIV/Gr (CaMKIV/Gr[i]) was 
prepared by substituting  the conserved Lys75 in the ATP-binding 
site of CaMKIV/Gr(wt) with a Glu residue by site-directed mu- 
tagenesis  using the  unique site  elimination method  (19). The 
constitutively active  CaMKIV/Gr mutant ACaMKIV/Gr(c) was 
prepared by replacing the Gln318 codon of CaMKIV/Gr(wt) with 
a stop codon. ACaMKIV/Gr(c) does not bind to and is not acti- 
vated by Ca2+/calmodulin. The double mutant constitutive/inactive 
ACaMKIV/Gr(i) was prepared by mutating Lys75 of ACaMKIV/ 
Gr(c) into a Glu. cDNA of all CaMKIV/Gr mutants were  se- 
quenced and ascertained  to be free  of errors.  The constitutively 
active human CaMKII-'ys mutant (CaMKII[c]) was a kind gift of 
Dr. Howard Schulman (Stanford University, Stanford,  CA)  and 
was generated by substituting Thr287 in the autoinhibitory do- 
main with an Asp residue  (20). CaMKII(c) was subcloned into 
the EcoR.I site ofpSG5 for use in our studies. 
The plasmid  IL-2 luciferase contains bp -326 to  +45 of the 
human IL-2 enhancer/promoter directing the transcription of a 
luciferase reporter gene (21). Nuclear factor  of activated  T  cells 
(NFAT) luciferase contains three copies of the NFAT site in the 
human IL-2 gene (21), and AP-1 luciferase contains two copies 
of the AP-1  site in the  rodent c~ chorionic gonadotropin gene 
(22). The plasmid CMV-luciferase contains a luciferase gene un- 
der the control of the immediate early promoter region of CMV 
(23). The plasmid c-fos-chloramphenicol  acetyl transferase (CAT) 
contains bp  -356 to  + 109 of the c-fos promoter coupled to a 
CAT gene  (24). The  plasmids  pEF-v-Ha-ras  and pEF-Ha-ras- 
N17 ras encode a constitutively active and a catalytically inactive 
mutant ofp21Ha-ras, respectively  (25). cDNA encoding the cy- 
toplasmic component of NFAT (NFATc) was fitted with EcoR.l 
linkers and subcloned into the EcoRI site of the vector pBJ5 (26). 
In Vitro Transcription~Translation Studies.  In these studies, 2 I~g 
of cDNA encoding either wild-type or mutant CaMKIV/Gr pro- 
teins were transcribed and translated in vitro using the TNT tran- 
scription and translation system  (Promega  Corp., Madison, WI) 
according to  the  instructions of the  manufacturer. When indi- 
cated, the proteins were metabolically labeled during the transla- 
tion process by including 4 p~Ci of [35S]methionine in the tran- 
scription/translation  reaction mixture. The labeled products were 
resolved  on a  10% denaturing acrylamide  gel  and visualized by 
autoradiography. 
Assay of Recombinant Kinase Activity.  R.ecombinant  CaMKIV/ 
Gr and CaMKII(c) proteins were expressed by in vitro transcrip- 
tion translation, as described above. Kinase assays were carried out 
for 10 min at 23~  in a final volume of 50 p~l containing  25 ~1 of 
the transcription/translation  reaction and 25 ~1 of a kinase reac- 
tion  mixture  consisting of 20  mM  Hepes,  pH  7.5,  10  mM 
MgC12, 50 IxM ATP, 4 btCi ~-[32p]ATP, 20 ~M of the substrate 
peptide  syntide-2  (Bachem,  Torrance,  CA),  and  either  5  mM 
CaC12 and 600 nM calmodulin (Pharmacia,  Piscataway,  NJ)  or 
5 mM EGTA. The reaction was terminated by spotting 25 b~l of 
the mixture onto P81 phosphocellulose  filters (Whatman, Maid- 
stone,  UK). The filters were washed  three times  in 0.5% phos- 
phoric acid, allowed to air dry, and counted. 
Detection of Recombinant Kinase Proteins in Cells.  Expression  of 
recombinant CaMKIV/Gr in cells was analyzed by immunoblot- 
ting using an anti-FLAG epitope antibody (Eastman Kodak Co., 
Rochester,  NY).  Cells transfected  with CaMKIV/Gr constructs 
were  lysed  on ice  for  15  rain in a  buffer containing 25  mM 
Hepes,  pH 7.5,  0.5% NP40, 50 mM NaC1, 25 mM NaH2PO  4, 
25 m/vl NaF, 12.5 mM Na4P207,  2 mM EDTA, 2 mM EGTA, 
1 mM Na3VO4, 100 mg/ml PMSF, and 10 mg/ml of the pro- 
tease inhibitor leupeptin. The lysates were cleared  of nuclei and 
other insoluble material by centrifugation at 16,000 g for 30 rain 
at 4~  100 btg of the lysate proteins was resolved by SDS-PAGE 
and then electroblotted onto nitrocellullose  membranes. The fil- 
ters were incubated for 1 h at room temperature in a Tris-buff- 
ered saline solution (TBST; 20 mM Tris, pH 7.4,  150 mM NaC1, 
and 0.1% Tween 20 detergent)  containing 5% nonfat milk; they 
were  then washed  and incubated for  1 h  more with M2  anti- 
FLAG epitope antibody at 1 ~g/ml in TBST solution. The filters 
were  then washed  and incubated with horseradish  peroxidase- 
conjugated goat  anti-mouse IgG  (Amersham  Corp.,  Arlington 
Heights,  IL). The blots were subsequently washed and developed 
using the  enhanced chemiluminescence system  for  peroxidase- 
based detection (Amersham Corp.). 
Endogenous CaMKIV/Gr in cells was also detected by immuno- 
blotting as detailed above but using as a primary antibody 1:1,000 
dilution of a rabbit antiserum that is directed against the terminal 
17 amino acids of the human enzyme (27). 
Expression  of recombinant CaMKII(c) was visualized by cal- 
modulin overlay blotting (28). Filters were incubated with bio- 
tinylated calmodulin at  1  p~g/ml in TBST solution containing 
CaC1/at 0.5 mM and MgC12 at 50 raM, and the two salts were 
also included in the entire immunoblotting  process. After wash- 
ing, the blots were incubated with horseradish peroxidase-conju- 
gated streptavidin (Amersham Corp.), then washed again and de- 
veloped using the enhanced chemiluminescence  system. 
Transfections and Reporter Assays.  Jurkat  Tag  cells were  sus- 
pended at  1.5  ￿  107 cells in 10% FCS RPMI medium, mixed 
with the indicated plasmids, then transfected by electroporation at 
250 V and 960 I-~F.  BJAB cells were suspended at 107 cells in 10% 
FCS DMEM medium and transfected  by electroporation at 220 
V and 960 jxF. HeLa cells were transfected by calcium phosphate 
precipitation. After transfection,  cells were handled as detailed in 
the figure legends. Luciferase and CAT activities were assayed as 
previously described  (29, 30). Results were normalized for pro- 
tein content and are expressed as fold induction over values ob- 
tained in cells transfected with reporter gene and empty vectors. 
Electrophoretic Mobility Shift Assays.  Nuclear extracts were pre- 
pared and electrophoretic mobility shift assays were conducted as 
previously described,  with  modifications (30). Cells  were  har- 
vested at  48  h  after transfection.  For PMA induction of AP-1, 
cells were stimulated with 25 ng/ml of PMA for 1 h before har- 
vesting. The cells were washed in PBS and then lysed in a buffer 
containing 10 mM Hepes, pH 7.4,  10 mM KC1, 1.5 mM MgC12, 
0.5  mM dithioerythritol, 0.2 mM PMSF,  10  p~g/ml leupeptin, 
and 0.025% NP40. The nuclei were pelleted and then extracted 
in a buffer containing  20 mM Hepes, pH 7.4, 420 mM NaC1, 1.5 
mM MgC12, 0.5 mM dithioerythritol, 0.2 mM EDTA, 0.2 mM 
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mobility shift assays, 5  ~.g of nuclear extracts  was incubated to- 
gether with 0.1  ng of 32p-labeled double stranded monomers of 
the  indicated  response  elements  in a buffer containing  10  mM 
Tris,  pH  7.5,  50  mM  NaC1,  1  mM  dithioerythritol,  0.5  mM 
EDTA,  5%  glycerol,  and  0.5-1  p,g/ml  poly(dI-dC).  Gel  shift 
probes  used  in  these  studies  included:  the  AP-l-binding  site 
found in the human metalothionein promoter, 5'-GATCCGT- 
GACTCAGCGCGG-3' (31); a mutant oligonucleotide derived 
i~om  the aforementioned AP-1  site  (mAP-l)  that displays poor 
aflfinity for AP-1,  5'-GATCCAAGACTCTGCGCGG-3' (32); 
and  the  routine  IL-2 distal NFAT-binding site,  5'-GATCGC- 
CCAAAGAGGAAAATTTGTTTCATACAG-3'  (33). For com- 
petition experiments,  100-fold molar excess of unlabeled oligo- 
nucleotide was included in the reaction mixture. After 30 n'fin of 
incubation at 23~  the reaction mixture was resolved on a pre- 
run 5% nondenaturing polyacrylamide gel, and the protein-DNA 
complexes were visualized by autoradiography. 
Results 
Characterization of CaMKIV/Gr Constructs.  To  examine 
the role of CaMKIV/Gr in T  cell activation, we generated 
cDNA constructs encoding recombinant wild-type and mu- 
tant  CaMKIV/Gr  proteins  and  examined  the  capacity  of 
these proteins to recapitulate  some of the activation events 
associated with Ca  2+ signaling in T  cells.  Proteins encoded 
by these  constructs include  CaMKIV/Gr(wt)  and its inac- 
tive counterpart CaMKIV/Gr(i),  ACaMKIV/Gr(c) and the 
constitutively  active  mutant  and  its  inactive  counterpart 
ACaMKIV/Gr(i).  We  have  also  utilized  in  our  studies  a 
construct generated by Nghiem et al.  (20), CaMKII(c). It is 
an  isoform of CaMKII that  is  expressed  in several  tissues, 
including human T  lymphocytes. CaMKII(c) binds to and 
its constitutive activity is upregulated by Ca2+/calmodulin, 
and it was used in our studies as a kinase specificity control. 
The  characteristics  of  recombinant  CaMKIV/Gr  and 
CaMKII(c) proteins are illustrated  in Fig.  1.  Fig.  1 A  shows 
the  migration  profile  on  SDS/PAGE  of  recombinant 
CaMKIV/Gr  and  CaMKII(c)  proteins  that  have  been  ex- 
pressed  in  vitro  and  labeled  with  [35S]methionine  using  a 
rabbit  reticulocyte  lysate  transcription  translation  system. 
CaMKIV/Gr(wt)  and CaMKIV/Gr(i)  resolved as a  58-kD 
band on SDS/PAGE. CaMKII(c) resolved as a single 60-kD 
band, whereas both ACaMKIV/Gr(c) and ACaMKIV/Gr(i) 
resolved as a 40-kD band.  Fig.  1 B demonstrates the activ- 
ity  profile  of the  respective  recombinant  kinase  proteins. 
Specifically, CaMKIV/Gr(wt)  mediated Ca2+/calmodulin  - 
dependent  phosphorylation  of substrate  peptide  whereas 
ACaMKIV/Gr(c)  exhibited  constitutive  activity indepen- 
dent of Ca2+/calmodulin.  In contrast,  CaMKIV/Gr(i)  and 
ACaMKIV/Gr(i) were both inactive. CaMKII(c) exhibited 
constitutive activity that was further upregulated by Ca2+/ 
calmodulin. 
Figure 1.  Characterization of recombinant CaMK proteins. (A) SDS/PAGE analysis of 3SS-labeled, in vitro transcribed and translated recombinant 
CaMKIV/Gr and CaMKI[(c) proteins. The numbers on the left represent mol wt markers. (B) Phosphorylation  of  the substrate peptide syntide-2 by in 
vitro transcribed and translated recombinant CaMK proteins. Results are expressed as picomoles of  phosphate incorporated into peptide substrate over the 
course of  the reaction and represent means of  triplicate determinations; similar results were found in two other experiments. 
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in  transfected Jurkat  cells  by immunoblotting  and/or  cal- 
modulin  overlay assays.  Fig.  2  A  demonstrates  that  both 
CaMKIV/Gr(wt) and CaMKIV/Gr(i) were expressed as two 
monomeric 0t/J3 bands with molecular masses of 58 and 60 
kD,  respectively.  ACaMKIV/Gr(c)  was  expressed  as  two 
bands migrating with  molecular masses of 40  and  42  kD. 
The latter band represents an autophosphorylated form of 
the 40-kD species (Chatila, T.,  unpublished observations). 
ACaMKIV/Gr(i) was expressed at lower, levels as a  single 
40-kD band.  In separate studies,  we established that three 
independent inactivating mutations all resulted in decreased 
expression  of ACaMKIV/Gr(c),  indicating  that  the  low 
level of expression  of ACaMKIV/Gr(i)  in Jurkat  cells  re- 
flects  a  requirement  for an  autophosphorylation  event  to 
stabilize this mutant (Chatila, T., and A.R.  Means,  manu- 
script in preparation). We have also determined that when 
expressed at levels comparable with  those  of ACaMKIV/ 
Gr(i), the constitutively active kinase mutant exhibited ac- 
tivity equivalent to ,'-d5% of that found with unrestricted 
ACaMKIV/Gr(c)  expression.  In  some  experiments  (e.g., 
Fig.  2 A), low levels of a split product of CaMKIV/Gr(wt) 
could be detected that comigrated with ACaMKIV/Gr(c). 
Fig.  2  B  demonstrates that  CaMKII(c) was well expressed 
in Jurkat cells  as detected by calmodulin overlay assays. In 
separate  studies,  it  could  be  demonstrated  by  calmodulin 
overlay  assays  that  the  levels  of CaMKII(c)  achieved  in 
Figure  2.  Expression of wild-type and  mutant CaMKIV/Gr and 
CaMKII(c) in Jurkat cells. (A) Expression of CaMKIV/Gr derivatives. 
100  Ixg of protein lysates derived from cells that had been transiently 
transfected with the indicated CaMKIV/Gr construct were resolved by 
SDS/PAGE and  probed for  kinase expression using an  anti-FLAG 
epitope antibody, as described in Materials and Methods. (B) Expression 
of CaMKII(c) in Jurkat cells. Lysates  derived from cells transfected with 
pSG5 vector alone or with CaMKII(c)  in pSG5 were resolved  by SDS/ 
PAGE and probed for calmodulin-binding  proteins as described in Mate- 
rials and Methods. (Arrow)  Position of the CaMKII(c)  band. 
lymphoid  and  nonlymphoid  cells  closely  approximated 
those of recombinant CaMKIV/Gr(wt) (data not shown), 
Activation  of AP-l-dependent  Transcription by  CaMKIV/ 
Gr.  Ca  2+ signaling pathways have previously been impli- 
cated in the activation of AP-1 in T  lymphocytes by mech- 
anisms that include transcriptional activation ofc-fos (34) and 
posttranscriptional activation of a c-Jun kinase termed JNK 
or stress-activated protein kinase (35,  36). To determine the 
capacity of CaMKIV/Gr to  activate AP-l-dependent  tran- 
scription, Jurkat cells were transiently cotransfected with the 
respective CaMKIV/Gr construct together with an AP-1- 
responsive luciferase reporter gene, and the cells were sub- 
sequently examined for luciferase activity. Fig.  3 A  demon- 
strates  that  transfection  of Jurkat  cells  with  a  construct 
encoding CaMKIV/Gr(wt) resulted in an eightfold upreg- 
ulation of luciferase activity. Furthermore, transfection of a 
cDNA  construct  encoding  a  constitutively active form of 
the kinase resulted in 50-fold induction  ofluciferase activ- 
ity. Significantly, both wild-type and the constitutively ac- 
tive kinase mutant acted in synergy with the phorbol ester 
PMA  and  with  the  TCtk-stimulating lectin  PHA  to  up- 
regulate  the  induction  of AP-1  reporter  gene  expression 
(Fig.  3  B).  In contrast,  inactive CaMKIV/Gr mutants  de- 
rived from the  wild-type  and  constitutively active kinase 
species failed to  induce  the  transcription  of the  AP-1  re- 
porter or to enhance PMA or PHA-induced reporter gene 
expression. 
The multifunctional  CaMKII is similar to CaMKIV/Gr 
in that both are homologous, Ca2+/calmodulin-dependent 
protein  kinases that  exhibit broad substrate specificity and 
that  phosphorylate  the  same  minimal  consensus  substrate 
sequence  (RXXS/T)  (4).  We therefore examined the  ca- 
pacity of CaMKII(c) for its capacity to  induce  AP-1.  We 
found that  CaMKII(c) failed to induce AP-1  activation in 
transfectedJurkat cells (Fig. 3 A) or to upregulate induction 
by phorbol  esters  and  PHA  of AP-1  reporter  expression 
(Fig.  3 B).  Other reports have documented moderate inhi- 
bition  of AP-1  activation  by  CaMKII(c)  (37,  38).  The 
specificity of CaMKIV/Gr induction ofAP-1 reporter gene 
expression was also ascertained by the failure of ACaMKIV/ 
Gr(c) to upregulate the transcription of a luciferase reporter 
gene driven by the  CMV immediate early gene promoter 
or to enhance the upregulation of the CMV promoter ac- 
tivity by PMA and PHA (Fig.  3  C). 
Induction of AP-l-dependent transcription by CaMKIV/ 
Gr was associated with increased AP-1  DNA-binding  ac- 
tivity. Electrophoretic mobility shift assays performed using 
a  radiolabeled  AP-l-binding  oligonucleotide  probe  re- 
vealed  enhanced  AP-1  DNA-binding  activity  in  nuclear 
extracts of ACaMKIV/Gr(c)-transfected Jurkat cells as com- 
pared  with  those  extracts  isolated  from  cells  transfected 
with  vector alone or with  ACaMKIV/Gr(i)  (Fig.  4).  The 
increase in AP-1 DNA-binding activity by ACaMKIV/Gr(c) 
was less than that  observed upon  treatment of Jurkat  cells 
with PMA. This can be explained in part by the low num- 
ber of  Jurkat cells successfully transfected with ACaMKIV/ 
Gr(c)  (typically 20-30%)  as  compared with  100%  of cells 
being amenable to PMA treatment. 
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Previous studies have demonstrated that p21~-regulated 
signaling pathway(s) are involved in TCR couphng to AP-1 
activation (39).  To examine the  potential role of p21 r~ in 
CaMKIV/Gr-dependent induction ofAP-1, we monitored 
AP-1  activity in Jurkat cells  cotransfected with  CaMKIV/ 
Gr and either a mutationally activated or a dominant nega- 
tive p21 r~ mutant. Fig. 5 A  demonstrates that CaMKIV/Gr 
acted  in  synergy with  activated  p2U%  encoded  by  v-Ha- 
ras,  in inducing AP-l-dependent  transcription.  This result 
agrees with the data shown in Fig. 3  B  since both PHA  and 
PMA  have  been  shown  to  convert  p21 =s  to  its  active, 
GTP-bound  state and thereby activate p21r~-coupled path- 
ways.  However,  Fig.  5  B  demonstrates  that  CaMKIV/Gr 
induced AP-1  activation by mechanism(s) that were largely 
independent  of p21 =s since  cotransfection of the  dominant 
negative p21 r~ mutant  Ha-ras-N17  resulted in only modest 
inhibition  (<20%  in  three  independent  experiments).  In 
contrast,  and  in  agreement  with  previous  studies,  the  Ha- 
ras-N17 mutant inhibited the induction of AP-1  activity by 
PMA  by ~85%. 
A  possible mechanism by which Ca  2+ signaling pathways 
may  activate AP-1  is through  induction  of c-fos  transcrip- 
tion  (34).  The  capacity  of CaMKIV/Gr  to  activate  c-fos 
transcription was examined by cotransfecting kinase deriva- 
tives  and  a  reporter  gene  regulated  by the  c-fos  enhancer/ 
Figure 3.  Activation of AP-1 by CaMKIV/Gr. (A) CaMKIV/Gr inde- 
pendently activates AP-l~tependent gene transcription in T  cells. Jurkat 
Tag cells were transiently cotransfected with 5 Ixg of AP-l-luciferase re- 
porter gene together with 30 ~g of empty pSG5 vector (Vector) or pSG5 
encoding wild-type CaMKIV/Gr (CaMKIV/Gr[wt]), inactive CaMKIV/ 
Gr  (CaMKIV/Gr[i]),  constitutively  active  CaMKIV/Gr  (ACaMKIV/ 
Gr[c]), double mutant constitutive/inactive (ACaMKIV/Gr[i]),  or a con- 
stitutively active CaMKII-~/B mutant (CaMKII[c]). Transfected cells were 
incubated for 48 h, then harvested and assayed for luciferase activity.  (B) 
CaMKIV/Gr upregulates  AP-1 activation by T  cell mitogens. Jurkat Tag 
cells cotransfected with the AP-1  reporter gene and the indicated con- 
structs were stimulated for 6 h with PHA-P (10 ~g/ml) or PMA (25 ng/ 
ml). (C) CaMKIV/Gr does not activate transcription from the CMV im- 
mediate early gene promoter. Jurkat Tag cells were cotransfected  with 0.5 
~g of CMV-luciferase reporter gene (23); 30 I~g of the indicated con- 
structs were then stimulated for 6 h with PHA-P or with PMA. Data in A 
and B represent means +  SEM of three to five independent experiments. 
Data in C are representative of two independent experiments. 
Figure 4.  Upregulation  of nuclear  AP-1  DNA-binding  activity  by 
CaMKIV/Gr. Nuclear extracts were prepared from Jurkat Tag cells that 
were transiently transfected with either pSG5 vector (Vector) or with the 
indicated kinase cDNA. 5 ~g of the respective extract was incubated with 
32p-labeled AP-1 ohgonucleotide in the absence or presence of excess un- 
labeled competitor AP-1  oligonucleotide (Comp.), and the bound com- 
plexes  were  resolved  on  5%  nondenaturing acrylamide  gel.  (Vector + 
PMA) Nuclear extracts derived from Jurkat Tag cells that were transfected 
with pSG5 vector and that were treated with PMA at 25 ng/ml for 1 h 
before cell lysis. (Probe  lane) ILadiolabeled  reaction mixture incubated in 
the absence of nuclear proteins. (Arrow) Specific AP-1/DNA complexes. 
The lower band represents  a nonspecific DNA-protein complex, while 
unbound radiolabeled probe was allowed to run out of the gel. Results 
are representative of two independent experiments. 
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Figure 5.  Characterization  of AP-1 activation by CaMKIV/Gr. (A) Synergistic activation  of AP-1  by CaMKIV/Gr and p21 v-H~-'a'.  Jurkat Tag cells 
were cotransfected with 5 p,g of the AP-1 reporter gene and 30 ~g of the respective kinase construct together with 30 p,g of empty pEF vector or pEF 
containing  the constitutively active p21 ~  mutant v-Ha-ras (pEF-vHa-ras) (25). The cells were incubated  for 48 h in the absence of any added stimulus; 
they were then harvested and assayed for luciferase activity. Data are expressed as fold induction over levels achieved upon cotransfection  of AP-1  re- 
porter gene together with empty pSG5 and pEF vectors. (B) Resistance of  AP-i activation by CaMKIV/Gr to inhibition by Ha-ras-N17. Jurkat Tag cells 
were cotransfected as per A with AP-1 reporter and the indicated  kinase constructs together with empty pEF vector or pEF containing  the dominant 
negative p21 r~s mutant  Ha-ras N17 (pEF-Ha-ras-N17).  PMA induction of AP-1 was performed by treatment  with 25 ng/ml of PMA during the last 6 h 
of the incubation  period.  (C) Transcriptional  activation of c-fos enhancer/promoter by CaMKIV/Gr. Jurkat Tag cells were cotransfected with 5 ~g of 
c-fos (-356 to +109)-CAT reporter gene (24), and 30 ~g of the indicated kinase construct was then harvested and assayed for CAT activity. (D) Resis- 
tance of AP-1  activation by CaMK IV/Gr to inhibition  by cyclosporin A. Jurkat  Tag cells were cotransfected with either the AP-1 or NFAT reporter 
gene (21) together with the indicated kinase construct  and were thereafter treated for 48 h in culture with cyclosporin A at 100 ng/ml or with solvent 
alone. Cells transfected with the NFAT luciferase reporter gene were treated with PHA-P at 10 ~g/ml during the last 6 h of the incubation  period to in- 
duce reporter expression. Data presented  in A, B, and D are representative  of at least three independent experiments  for each panel, and data in C are 
means values -  SEM of three experiments. 
promoter.  Fig. 5  C  demonstrates  that ACaMKIV/Gr(c)  is a 
potent inducer of c-fos reporter gene transcription in Jurkat 
cells.  In contrast,  CaMKII(c)  inhibited  (>90%)  basal tran- 
scription of the c-fos reporter. 
Ca  2+ may also act in synergy with phorbol esters to acti- 
vate  AP-1  in  T  cells  by  a  calcineurin-dependent  mecha- 
nism that involves JNK/SAPK,  a  member  of the mitogen- 
activated protein kinase family that phosphorylates c-Jun and 
upregulates its transcriptional activity (35, 36).  If calcineurin 
were  to  be  involved  in  CaMKIV/Gr-dependent  activa- 
tion, then it follows that the response would be sensitive to 
the immunosuppressive  drug cyclosporin A. Fig. 5  D  dem- 
onstrates  that  this  was  not  the  case,  since  AP-1  activation 
by  CaMKIV/Gr  is  cyclosporin  A  resistant,  whereas  the 
drug,  as  expected,  blocks  PHA  induction  of  a  NFAT- 
driven reporter  gene.  This  result agrees  with  our observa- 
tion that TCR-dependent  activation of CaMKIV/Gr  is cy- 
closporin A  resistant (data not shown). 
Activation  of NFA T-dependent  Transcription  in  T  Cells  by 
CaMKIV/Gr.  The  transcriptional  complexes  NFAT  and 
NFIL2-A regulate lymphokine gene transcription in T  cells 
and contain AP-1 components that are essential for the func- 
tion  of these  complexes  (40,  41).  In  the  case  of NFAT, 
NFATc  (26)  translocates  to  the  nucleus  to  combine  with 
an  AP-1  (nuclear)  component  (21,  33,  42)  and  activates 
transcription from specific response elements. Assembly and 
activation  of NFATc  in  the  nucleus  is  thought  to  reflect 
the action of two signaling pathways:  (a) a Ca2+-dependent 
pathway  involving the  Ca2+/calmodulin-dependent  phos- 
phatase  calcineurin  and  mediating NFATc  translocation  to 
106  Ca  2+ Signaling Pathways in T  Lymphocytes the  nucleus  (43); and  (b)  a  PKC-  and  p21r~-dependent 
pathway mediating activation of AP-1  (44). To determine 
if AP-1  activation by CaMKIV/Gr is associated  with in- 
creased  NFAT  activity,  we  examined  if  CaMKIV/Gr 
modulates basal and mitogen-activated transcription from a 
NFAT-driven  repoter  gene  transfected  into Jurkat  cells. 
Fig.  6  A  demonstrates that CaMKIV/Gr upregulated the 
activation of NFAT-dependent transcription by PMA and 
the Ca  2+ ionophore ionomycin. In contrast, and in agree- 
ment with previous studies (37, 38),  the constitutively ac- 
tive CaMKII(c) moderately inhibited NFAT activation un- 
der the same  conditions.  The  observed  synergy between 
CaMKIV/Gr and ionomycin in  inducing NFAT-depen- 
dent transcription is of interest since it suggests synergistic 
interaction between  calcinuerin,  which  mediates NFATc 
translocation to the nucleus, and CaMKIV/Gr, which acti- 
vates AP-1.  This  interpretation is in  agreement with the 
previously reported  capacity of transfected AP-1  compo- 
nents,  especially  c-fos,  to  promote  NFAT  activation  by 
ionomycin in Jurkat cells (21). 
In line  with the  activation of NFAT-driven transcrip- 
tion, CaMKIV/Gr also enhanced the transcriptional activa- 
tion by PMA and ionomycin of a reporter gene driven by 
the complete IL-2 enhancer/promoter and transfected into 
Jurkat cells. This effect was more pronounced in the presence 
of suboptimal concentrations of PMA, in agreement with 
the synergistic induction of AP-1 by PMA and CaMKIV/ 
Gr (Fig. 6 B). 
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Figure  6.  Upregulation of NFAT  and IL-2  enhancer/ 
promoter activities by CaMKIV/Gr in Jurkat cells.  (A)Jur- 
kat Tag cells  were  cotransfected with 5  I~g of NFAT lu- 
ciferase reporter  together with 30  p~g of pSG5  vector or 
pSG5  vector  containing  the  indicated  kinase  construct. 
The cells were incubated for 48 h and thereafter treated for 
6  h  with  either medium alone,  ionomycin at  1  ~M,  or 
with PMA at 25 ng/ml and ionomycin at 1  IJ,  M. Results 
are means of three experiments -+ SEM and are expressed 
as fold induction over values obtained with empty pSG5 
vector alone.  (B) Jurkat Tag cells were cotransfected with 
an  IL-2  enhancer/promoter-driven  luciferase  reporter 
gene (21) and the indicated kinase construct and incubated 
as above; they were then stimulated with ionomycin at 1 
p,M and PMA at 2.5  or 25 ng/ml, as indicated.  Data are 
representative of three independent experiments. Figure 7.  lmmunoblot  analysis of CaMKIV/ 
Gr  expression  in  Jurkat,  BJAB,  and  HeLa 
cells. 100  b~g of protein lysates derived from 
the  respective  cell  populations  was  resolved 
by SDS/PAGE and  probed  for  endogenous 
CaMKIV/Gr using  a polyclonal  rabbit  anti- 
human  CaMKIV/Gr antiserum,  as described 
in Materials and Methods.  (Arrow)  Position  of 
the two CaMKIV/Gr isoforms. 
Reconstitution of NFAT-dependent  Transcription in  Non-T 
Cells by CaMKIV/Gr and NFA Tc.  Endogenous  CaMKIV/ 
Gr in Jurkat cells is activated by mitogens and is thus likely 
to mask the full magnitude  of NFAT  activation by recom- 
binant CaMKIV/Gr  transfectants  (6,  16).  We therefore ex- 
amined  the  capacity  of CaMKIV/Gr  transfectants  to  acti- 
vate NFAT-dependent  transcription  in non-T  cell systems 
that lack endogenous CaMKIV/Gr  expression.  Fig. 7  dem- 
onstrates  that  the  two  ceil lines  used  in  these  studies,  the 
human  B  cell  Burkitt  lymphoma  cell line  BJAB  (11)  and 
the  human  cervical  adenocarcinoma  cell line  HeLa,  were 
lacking  in  endogenous  CaMKIV/Gr  expression,  as  de- 
tected  by  immunoblotting  with  a  specific  anti-human 
CaMKIV/Gr  antiserum.  Cells were transfected with cDNA 
encoding  NFATc  and  CaMKIV/Gr,  either  alone  or  in 
combination,  and  transcription  from  reporter  gene  con- 
structs  driven  by  the  NFAT  response  element  or  by  the 
complete  IL-2  enhancer/promoter  was  analyzed.  Fig.  8  A 
demonstrates  that  a  construct  encoding  NFATc  was  inef- 
fective  in  activating  transcription  of the  NFAT  reporter 
gene  in BJAB  in  the  absence  of a  costimulus.  Stimulation 
with PMA  resulted in a modest level of reporter  transcrip- 
tion.  Transfection  of BJAB cells with a  construct  encoding 
ACaMKIV/Gr(c)  resulted  in  modest  activation  of NFAT- 
Figure 8.  Reconstitution of NFAT and IL-2 promoter activities by CaMKIV/Gr and NFATc in kinase-negative cells. (A and B) 107 BJAB cells were 
cotransfected by electroporation  with 5 p~g of either NFAT or IL-2 luciferase reporters and 30 b~g of the indicated kinase construct  with or without an 
additional 5 ~g ofNFATc cDNA in pBJ5 vector (26). The cells were incubated for 48 h and then treated as follows and left incubating for an additional 
6 h before  harvesting.  (Medium) Cells receiving kinase construct  alone and  otherwise  left untreated;  (PMA) cells receiving  kinase construct  alone and 
treated with PMA at 25 ng/ml; (Medium/NFATc)  cells cotransfected with NFATc and kinase constructs  but otherwise  left untreated;  (PMA/NFATc) 
cells cotransfected with NFATc and kinase constructs and treated with PMA at 25 ng/ml. Results  represent  mean values of three independent experi- 
ments  +  SEM and are expressed as fold induction over values obtained in cells transfected with reporter gene and empty pSG5 and pBJ5 vectors and in- 
cubated in medium alone. (C and D) HeLa cells were cotransfected by the Ca  2+ phosphate  method with 2.5 ~g of either a NFAT or a IL-2 enhancer/ 
promoter~driven  reporter gene and  15 ~g of the indicated  kinase construct  with or without an additional 2.5 ~g ofNFATc cDNA in pBJ5. The cells 
were incubated for 48 h and thereafter treated for 6 h as per A and B. Results represent mean values of three independent experiments  -+ SEM. 
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likely  mediated by endogenous NFAT proteins  normally 
found in B  cells  and was  abrogated upon treatment  with 
cyclosporin A  (data not shown). In contrast, cotransfection 
of of BJAB  cells  with  constructs  encoding  ACaMKIV/ 
Gr(c)  and  NFATc  resulted  in  the  activation  of NFAT- 
driven  reporter  gene  expression  to  levels  25-fold  higher 
than those obtained with NFATc alone in the presence of 
PMA and 10-fold higher than those induced upon transfec- 
tion of BJAB cells with  CaMKIV/Gr(c)  alone.  Induction 
of the  NFAT  reporter  gene  expression  by  NFATc  and 
ACaMKIV/Gr(c)  was  further  upregulated  by  PMA  by 
about twofold, which is consistent with the observed syn- 
ergy between PMA/P,  as and CaMKIV/Gr in upregulating 
AP-1 function (Figs. 3 and 5). 
The results  obtained in BJAB cells were reproduced in 
the human adenocarcinoma cell line HeLa. Fig.  8  C dem- 
onstrates  that a construct encoding NFATc was ineffective 
in  activating transcription  of the  NFAT reporter  gene  in 
HeLa cells. Similarly,  transfection of a construct encoding 
ACaMKIV/Gr(c) failed  to activate NFAT-driven reporter 
gene  expression.  In contrast,  cotransfection of HeLa cells 
with  constructs  encoding  ACaMKIV/Gr(c)  and  NFATc 
resulted  in  vigorous activation  of NFAT-driven reporter 
gene expression. Induction of the NFAT reporter gene ex- 
pression by NFATc and ACaMKIV/Gr(c) was further up- 
regulated  by  PMA,  similar  to  what  was  observed  with 
BJAB cells. The validity of these results was extended to an 
IL-2  enhancer/promoter-driven  luciferase  reporter  gene, 
where  ACaMKIV/Gr(c)  was  found  to  synergize  with 
NFATc to drive the transcription of this  reporter in both 
BJAB and HeLa cells  (Fig.  8,  B and D).  The specificity of 
CaMKIV/Gr stimulation of NFATc activity in BJAB and 
HeLa cells was suggested by the failure  of CaMKII(c) to ac- 
tivate transcription of the analyzed reporter genes (Fig. 8). 
To analyze the mechanism(s) by which CaMKIV/Gr(c) 
synergized with NFATc in inducing NFAT and IL-2 re- 
porter gene  expression in  non-T cells,  we  examined nu- 
clear  extracts  derived from transfected  HeLa cells  for the 
presence of NFAT DNA-binding activity using an oligo- 
nucleotide  corresponding to  the  distal  NFAT  site  in  the 
murine  IL-2  promoter.  This  oligonucleotide  binds  to 
NFAT proteins both in the absence and in the presence of 
associated  AP-1  components  to  give  rise  to  two  distinct 
DNA-protein complexes that can be resolved on PAGE: a 
faster  migrating complex containing NFAT and  a  slower 
complex containing NFAT/AP-1 (33). Fig. 9 demonstrates 
that nuclear extracts of HeLa cells that have been transfected 
with empty vectors alone exhibited  no NFAT-specific DNA- 
protein complexes. Transfection with NFATc induced the 
appearance of two NFAT-specific complexes: a dominant, 
higher mobility complex (Fig. 9, arrow) and a minor slower 
moving complex (Fig.  9, arrowhead). The presence of these 
complexes was not inhibited by cyclosporin A, indicating 
that recombinant NFATc gained entry into nuclei of un- 
stimulated HeLa cells by a calcineurin-independent mecha- 
nism (data not shown). Transfection of CaMKIV/Gr(c) in- 
duced no demonstrable NFAT-specific binding activity. In 
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Figure 9.  Upregulation  ofNFAT DNA-binding  activity by CaMKIV/ 
Gr. Nuclear extracts were prepared from HeLa cells that had been tran- 
siently transfected with the indicated construct(s) as detailed in the legend 
to Fig. 8. 5 Ixg of the respective extract was incubated with 32p-labeled 
oligonucleotide probe corresponding  to the murine IL-2  distal NFAT  site 
in the absence or presence of 100-fold molar excess of unlabeled NFAT, 
AP-1, or mutant AP-1 (mAP1) competitor oligonucleotide, as indicated. 
The bound complexes were resolved on 5% nondenaturing acrylamide 
gel. (Probe  lane) lkadiolabeled reaction mixture incubated in the absence 
of nuclear proteins. (Arrowhead)  DNA complexes containing NFAT pro- 
teins together with AP-1; (arrow) complexes containing NFAT proteins. 
The bottom two bands represents nonspecific DNA-protein complex, 
while unbound radiolabeled probe was allowed to run out of  the gel, Re- 
sults are representative of  five independent experiments. 
contrast,  cotransfection of  both NFATc and CaMKIV/Gr(c) 
resulted in marked increase in the upper complex, consis- 
tent with the induction of AP-1 activity by CaMKIV/Gr. 
It also  resulted  in  some increase  in the  abundance  of the 
lower complex, consistent with either  enhanced transport 
of NFATc  into  the  nucleus  and/or  increased  retention. 
The specificity of NFAT-DNA complexes was ascertained 
by the capacity of excess  unlabeled NFAT-binding oligo- 
nucleotide  to  competitively  inhibit  both  NFAT-DNA 
complexes.  Addition  of excess  unlabeled  AP-l-binding 
oligonucleotide specifically  inhibited  the  upper  complex, 
consistent  with  the  presence  of AP-1  in  that  complex, 
whereas mutant AP-l-binding oligonucleotide, which ex- 
hibits  poor  affinity  to  AP-1,  inhibited  neither  complex. 
These  results  indicated that the  effects  of CaMKIV/Gr(c) 
on NFAT-driven transcription could be accounted for,  at least in part, by the capacity of the kinase to activate AP-1 
expression. 
Discussion 
The present study establishes  the role of CaMKIV/Gr as 
a  transducer  of Ca2+-dependent  activation  signals  in  T 
lymphocytes.  CaMKIV/Gr  upregulates  NFAT  and  IL-2 
enhancer/promoter-dependent transcription in T cells and, 
importantly, reconstitutes the capacity of NFATc to direct 
transcription  from  the  respective  regulatory  sequence  in 
non-T  cells.  The promotion by  CaMKIV/Gr  of NFAT 
and  IL-2  enhancer/promoter-dependent  transcription  is 
due in part to the induction by the kinase of the transcrip- 
tion factor AP-1. This is the first example of AP-1  activa- 
tion by a  CaMK,  and  the  results herein provide a novel 
mechanism by which Ca  2+ signaling upregulates AP-1 func- 
tion. CaMKIV/Gr induces AP-1  in part by activating the 
transcription of genes encoding AP-1  components. This is 
supported by the demonstration that CaMKIV/Gr upregu- 
lates  the  transcription  in Jurkat  cells  of a  reporter  gene 
driven by the c-fos promoter/enhancer and by the demon- 
stration that CaMKIV/Gr induces the transcription of c-Jbs 
in PC12 rat pheochromocytoma cells. CaMKIV/Gr induc- 
tion of  c-Jbs transcription proceeds by a serum response factor- 
dependent mechanism in  contrast to induction by p21 ras, 
which is mediated by the serum response factor-associated 
protein Elk-1  (45).  This illustrates  how CaMKIV/Gr and 
p21 ~  can act independently yet synergistically to upregu- 
late AP-1  function. It remains to be determined whether 
CaMKIV/Gr  activates  transcription  of  genes  encoding 
other AP-1 components and whether it additionally upreg- 
ulates AP-1 activity by a posttranscriptional mechanism. 
Consistent with its induction ofAP-1, CaMKIV/Gr up- 
regulated the activation by mitogens of NFAT-dependent 
transcription in Jurkat cells. It also synergized with recom- 
binant NFATc in promoting NFAT-dependent transcription 
in BJAB and HeLa cells. In the latter case, NFATc gained 
entry into the nucleus in the absence of a Ca2+-mobilizing 
signal. This probably resulted from overexpression of  NFATc 
in the cytosol leading to its transport into the nucleus in a 
calcineurin-independent manner. Whereas AP-1 induction 
provides an important mechanism underlying the activation 
of IL-2  transcription  by  CaMKIV/Gr,  additional  kinase- 
induced activation events may also be involved. This is in- 
dicated by the finding that CaMKIV/Gr greatly surpassed 
PMA  in  activating  transcription  of NFAT  and  IL-2  en- 
hancer/promoter--driven reporter genes in non-T cells. An 
effect on NFATc itself is possible,  suggested  by the observa- 
tion that CaMKIV/Gr increased NFAT DNA-binding ac- 
tivity in the nucleus.  It should be noted that NFATc (26) 
and its related factors NFATc2/p  (46),  NFATc3 (47),  and 
NFAT-X  (48)  contain numerous consensus phosphoryla- 
tion sites for CaMKIV/Gr and CaMKII. The role of these 
phosphorylation sites in positive and negative regulation of 
NFAT protein function remains to be determined. 
It is likely that activation of NFAT-dependent transcrip- 
tion in T  cells is a cooperative process between several sig- 
naling pathways and that it involves calcineurin, CaMKIV/ 
Gr, and PKC- and p2P~-dependent pathways.  However, 
unlike  the aforementioned transducers of TCR signaling, 
CaMKIV/Gr is distinguished by its selective expression in 
T  cells, particularly the CD4 + subset (6). This and the ca- 
pacity of CaMKIV/Gr to activate transcription from lym- 
phokine response elements suggests  that the kinase may be 
an important determinant of the type and level of expres- 
sion of lymphokine genes present in T  versus B  cells and 
possibly among different T  cell populations. 
In  contrast  to  the  salutary  effects of CaMKIV/Gr  on 
transcription  directed  from  lymphokine  regulatory  ele- 
ments,  the multifunctional CaMKII-~13  inhibits  transcrip- 
tion from these same elements.  It has been suggested that 
CaMKII may play a role in mediating negative effects of 
Ca  2§ signaling in lymphocytes, including anergy and nega- 
tive selection (37, 38). However, the outcome of Ca  2+ sig- 
naling in a particular T lymphocyte is more likely to be de- 
termined  by  a  complex  set  of interactions  between  the 
various CaZ+-responsive enzymes, including CaMKIV/Gr, 
CaMKII,  and  calcineurin.  The  contribution  of each  of 
these enzymes to the diverse effects of Ca  ~+ signaling in T 
lymphocytes remains to be fully mapped. 
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